Global Orphan Drug Pipeline Analysis

Published: December 2013
No. of Pages: 1690
  

In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry. With close to 65-70 Million people in the US & Europe having some kind of rare disease complaints, the increasing activities around the development of orphan drugs only imply that the appropriate treatments for unmet needs are increasing, thus increasing the profit margins in the future. As the Asian pharmaceutical markets are still in growth stage, the opportunities for orphan drugs in Asia are also immense and getting increasingly popular. It is expected that by 2020, the Asian orphan drugs market would witness steady growth.

“Global Orphan Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various orphan designated drugs being developed for the treatment of rare disease. Research report covers all the orphan designated drugs being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Orphan Drug market based upon development process.

Following parameters for each orphan designated drug profile in development phase are covered in “Global Orphan Drug Pipeline Analysis” research report:

  • Drug Profile Overview
  • Alternate Names for Drug
  • Active Indication
  • Phase of Development
  • Mechanism of Action
  • Brand Name
  • Patent Information
  • Orphan Designation by Indication, Country & Organisation
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • ATC Codes

Global Orphan Drug Pipeline by Clinical Phase:

  • Research: 3
  • Preclinical: 71
  • Clinical: 4
  • Phase-I: 61
  • Phase-I/II: 71
  • Phase-II: 198
  • Phase-II/III: 20
  • Phase-III: 103
  • Preregistration: 26
  • Registration: 17
  • Marketed: 244
  • Unknown: 1

Global Orphan Drug Pipeline Analysis

Table of Contents

1. Global Orphan Drugs Market Overview

2. Orphan Drug Clinical Development Phase: Unknown
2.1 Overview
2.2 Orphan Drug Profile in Clinical Phase

3. Orphan Drug Clinical Development Phase: Research
3.1 Overview
3.2 Orphan Drug Profile in Clinical Phase

4. Orphan Drug Clinical Development Phase: Preclinical
4.1 Overview
4.2 Orphan Drug Profile in Clinical Phase

5. Orphan Drug Clinical Drug Development Phase: Clinical
5.1 Overview
5.2 Orphan Drug Profile in Clinical Phase

6. Orphan Drug Clinical Development Phase: Phase-I
6.1 Overview
6.2 Orphan Drug Profile in Clinical Phase

7. Orphan Drug Clinical Development Phase: Phase-I/II
7.1 Overview
7.2 Orphan Drug Profile in Clinical Phase

8. Orphan Drug Clinical Development Phase: Phase-II
8.1 Overview
8.2 Orphan Drug Profile in Clinical Phase

9. Orphan Drug Clinical Development Phase: Phase-II/III
9.1 Overview
9.2 Orphan Drug Profile in Clinical Phase

10. Orphan Drug Clinical Development Phase: Phase-III
10.1 Overview
10.2 Orphan Drug Profile in Clinical Phase

11. Orphan Drug Clinical Development Phase: Pre-Registration
11.1 Overview
11.2 Orphan Drug Profile in Clinical Phase

12. Orphan Drug Clinical Development Phase: Registered
12.1 Overview
12.2 Orphan Drug Profile in Clinical Phase

13. Marketed Orphan Drug
13.1 Overview
13.2Marketed Orphan Drug Profiles

List of Tables

Each Drug Profile has Tables Representing Following Information:
Alternate Names
Originator & Owner
Collaborator
Technology Provider
Licensee
Highest Development Phase
Indications
Class
Mechanism of Action
ATC code
Designated Brand Name & Orphan Designation

Published By: PNS Pharma
Product Code: PNS Pharma19


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 400,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100